Non-viral gene transfer therapy for cystic fibrosis

Expert Opinion on Biological Therapy

Volumn 3, Issue 3, 2003, Pages 449-458

  Ziady, Assem G ^a,b   Davis, Pamela B ^c   Konstan, Michael W ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NONE

Author keywords

Cystic fibrosis; DNA complexes; Gene transfer

Indexed keywords

DNA; LIPID; MACROGOL; NAKED DNA; PLASMID DNA; POLYCATION; POLYETHYLENEIMINE; POLYLYSINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CHLORIDE TRANSPORT; CLINICAL TRIAL; COMPLEX FORMATION; CYSTIC FIBROSIS; DNA SEQUENCE; DNA VECTOR; GENE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; REVIEW;

ANIMALS; CYSTIC FIBROSIS; DRUG CARRIERS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 0038201998     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.3.3.449     Document Type: Review

References (100)

1. RIODAN JR, ROMMENS JM, KEREM B-S et al.: Identification of the cystic fibrosis gene: cloning and characterization complimentary DNA. Science (1989) 245:1066-1073.
2. ROSENBERG SA, ABERSOLD P, CORNETTA K et al.: Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. (1990) 323:570-578.
3. MARSHALL E: Gene therapy death prompts review of adenovirus vector. Science (1999) 286(5448):2244-2245.
4. TRAPNELL BC, CHU CS, PAAKKO PK et al.: Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. USA (1991) 88(15):6565-6569.
5. GROTH AC, OLIVARES EC, THYAGARAJAN B, CALOS MP: A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. USA (2000) 97(11):5995-6000.
6. LIU F, HUANG L: Development of nonviral vectors for systemic gene delivery. J. Control Release. (2002) 78(1-3):259-266.
7. ZIADY AG, DAVIS PB: Receptor-directed molecular conjugates for gene transfer. In: Methods In Molecular Medicine: Gene Therapy Protocols, vol. 69. Morgan J (Ed.), Humana Press, Inc. Totowa, NJ, USA (2001):25-48.
8. COCKETT MI: Technology evaluation: cystic fibrosis therapy, Genzyme. Curr. Opin. Mol. Ther. (1999) 1(2):279-283.
9. ZIADY AG, DAVIS PB: Molecular conjugates. In: Vector Targeting for Therapeutic Gene Delivery. Curiel DT, Douglas JT (Eds), John Wiley and Sons, Inc., Indianapolis, IN, USA (2002):63-86.
10. PLANK C, OBERHAUSER B, MECHTLER K, KOCH C, WAGNER E: The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. (1994) 269:12918-12924.
11. KALDERON D, RICHARDSON WD, MARKHAM AF, SMITH AE: Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature (1984) 311:33-38.
12. CHOW YH, O'BRODOVICH H, PLUMB J et al.: Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways. Proc. Natl. Acad. Sci. USA (1997) 94(26):14695-14700.
13. RAMALHO AS, BECK S, MEYER M, PENQUE D, CUTTING GR, AMARAL MD: Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. (2002) 27(5):619-627.
14. JIANG Q, ENGELHARDT JF: Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis. Eur. J. Hum. Genet. (1998)6(1):12-31.
15. ENGELHARDT JF, YANKASKAS JR, ERNST SA et al.: Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. (1992) 2(3):240-248.
16. JOHNSON LG, OLSEN JC, SARKADI B, MOORE KL, SWANSTROM R, BOUCHER RC: Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. (1992)2(1):21-25.
17. ZHANG Y, JIANG Q, DUDUS L, YANKASKAS JR, ENGELHARDT JF: Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways. Hum. Gene Ther. (1998) 9(5):635-648.
18. JOHNSON LG, BOYLES SE, WILSON J, BOUCHER RC: Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J. Clin. Invest. (1995) 95(3):1377-1382.
19. KOEBERL DD, HALBERT CL, KRUMM A, MILLER AD: Sequences within the coding regions of dotting Factor VIII and CFTR block transcriptional elongation. Hum. Gene Ther. (1995) 6(4):469-479.
20. KNOWLES MR, PARADISO AM, BOUCHER RC: In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene Ther. (1995) 6(4):445-455.
21. PARSONS DW, HOPKINS PJ, BOURNE AJ, BOUCHER RC, MARTIN AJ: Airway gene transfer in mouse nasal-airways: importance of identification of epithelial type for assessment of gene transfer. Gene Ther. (2000) 7(21):1810-1815.
22. DEMOLOMBE S, BARO I, BEBOK Z et al.: A method for the rapid detection of recombinant CFTR during gene therapy in cystic fibrosis. Gene Ther. (1996) 3(8):685-694.
23. ZIADY AG, KELLEY TJ, MILLIKEN E, FERKOL T, DAVIS PB: Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol. Ther. (2002) 5(4):413-419.
24. DAVIES JC, STERN M, DEWAR A et al.: CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am. J. Respir. Cell Mol. Biol. (1997) 16(6):657-663.
25. WAGNER JA, NEPOMUCENO IB, MESSNER AH et al.: A Phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. (2002) 13(11):1349-1359.
26. WALTERS RW, PILEWSKI JM, CHIORINI JA, ZABNER J: Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J. Biol. Chem. (2002) 277(26):23709-23713.
27. FERRARI S, KITSON C, FARLEY R et al.: Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther. (2001) 8(18):1380-1386.
28. ERNST N, ULRICHSKOTTER S, SCHMALIX WA et al.: Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J. Gene Med. (1999) 1(5):331-340.
29. LUKACS GL, HAGGIE P, SEKSEK O, LECHARDEUR D, FREEDMAN N, VERKMAN AS: Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. (2000) 275(3):1625-1629.
30. ALTON EW, STERN M, FARLEY R et al.: Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 353:947-954.
31. KNOWLES MR, NOONE PG, HOHNEKER K et al.: A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis. Hum. Gene Ther. (1998) 9(2):249-269.
32. ALTON E, GEDDES D, GILL D et al.: Measure and interpretation of CF gene therapy trial results. Mol. Ther. (2000) 2(1):34.
33. ZABNER J, CHENG SH, MEEKER D et al.: Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. (1997) 100(6):1529-1537.
34. LEE ER, MARSHALL J, SIEGEL CS et al.: Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. (1996) 7(14):1701-1717.
35. SAWA T, MIYAZAKI H, PITTET JF et al.: Intraluminal water increases expression of plasmid DNA in rat lung. Hum. Gene Ther. (1996) 7:933-941.
36. GLASSPOOL-MALONE J, STEENLAND PR, MCDONALD RJ et al.: DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor. J. Gene Med. (2002) 4:323-332.
37. CROOK K, MCLACHLAN G, STEVENSON BJ, PORTEOUS DJ: Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther. (1996) 3:834-839.
38. FARHOOD H, GAO X, SON K et al.: Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann. NY Acad. Sci. (1994) 716:23-35.
39. JIANG C, O'CONNOR SP, FANG SL et al.: Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum. Gene Ther. (1998) 9(11):1531-1542.
40. HYDE SC, SOUTHERN KW, GILEADI U et al.: Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (2000) 7:1156-1165.
41. SHI F, WASUNGU L, NOMDEN A et al.: Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem. J. (2002) 366(Pt 1):333-341.
42. CORNELIS S, VANDENBRANDEN M, RUYSSCHAERT JM, ELOUAHABI A: Role of intracellular cationic liposome-DNA complex dissociation in transfection mediated by cationic lipids. DNA Cell Biol. (2002) 21:91-97.
43. ZABNER J, FASBENDER AJ, MONINGER T, POELLINGER KA, WELSH MJ: Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. (1995) 270(32):18997-19007.
44. POLLARD H, REMY JS, LOUSSOUARN G, DEMOLOMBE S, BEHR JP, ESCANDE D: Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. (1998) 273:7507-7511.
45. LI S, HUANG L: In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. (1997) 4(9):891-900.
46. YEW NS, WANG KX, PRZYBYLSKA M et al.: Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum. Gene Ther. (1999) 10:223-234.
47. KRIEG AM: CpG motifs in bacterial DNA and their immune effects. Ann. Rev. Immunol. (2002) 20:709-760.
48. YEW NS, ZHAO H, WU IH et al.: Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. (2000) 1(3):255-262.
49. YEW NS, ZHAO H, PRZYBYLSKA M et al.: CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther. (2002) 5:731-738.
50. RUIZ FE, CLANCY JP, PERRICONE MA et al.: A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. (2001) 12(7):751-761.
51. BOUSSIF O, LEZOUALC'H F, ZANTA MA et al.: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethytenimine. Proc. Natl. Acad. Sci. USA (1995) 92:7297-7301.
52. GODBEY WT, WU KK, MIKOS AG: Poly(ethylenimine) and its role in gene delivery. J. Control Release. (1999) 60:149-160.
53. CHIOU HC, TANGCO MV, LEVINE SM et al.: Enhanced resistance to nudease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. Nucleic Acids Res. (1994) 22:5439-5446.
54. ZIADY AG, FERKOL T, DAWSON DV, PERLMUTTER DH, DAVIS PB: Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J. Biol. Chem. (1999) 274(8):4908-4916.
55. LIU G, LI D, PASUMARTHY M et al.: Nanoparticles of compacted DNA transfect post-mitotic cells. Mol. Ther. (2001) 3(Suppl.):S14.
56. MAURER PH: Antigenicity of polypeptides (poly-alpha amino acids). J. Immunol. (1962) 88:330-345.
57. KANTOR FS, OJEDA A, BENACERRAF B: Studies on artificial antigens: antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in Guinea pigs. Hum. Exp. Med. (1962) 117:55-69.
58. WU GY, WU CH: Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. (1987) 262:4429-4432.
59. ZATOUKAL K, WAGNER E, COTTEN M et al.: Transferrinfection: a highly efficient way to express gene constructs in eukaryotic cells. Ann. NY Acad Sci. (1992) 660:136-153.
60. FERKOL T, KAETZEL CS, DAVIS PB: Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. J. Clin. Invest (1993) 92:2394-2400.
61. MIDOUX P, MENDES C, LEGRAND A et al.: Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res. (1993) 21:871-878.
62. MONSIGNY M, ROCHE AC, MIDOUX P, MAYER R: Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv. Drug. Delivery Rev. (1994) 14:1-24.
63. CHEN J, STICKLES RJ, DAISCENDT KA: Galactosylated histone-mediated gene transfer and expression. Hum. Gene Ther. (1994) 5:429-435.
64. PERALES JC, FERKOL T, MOLAS M, HANSON RW: An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur. J. Biochem. (1994) 226:255-266.
65. ERBACHER P, BOUSSER MT, RAIMOND J, MONSIGNY M, MIDOUX P, ROCHE AC: Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte derived macrophages. Hum. Gene Ther. (1996) 7:721-729.
66. ZIADY AG, PERALES JC, FERKOL T et al.: Gene transfer into hepatocyte cell lines via the serpin enzyme complex (SEC) receptor. Am. J. Physiol. (1997) 273:G545-G552.
67. ZIADY AG, FERKOL T, GERKEN T, DAWSON DV, PERLMUTTER DH, DAVIS PB: Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells. Gene Ther. (1998) 5(12):1685-1697.
68. FAJAC I, BRIAND P, MONSIGNY M, MIDOUX P: Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum. Gene Ther. (1999) 10(3):395-406.
69. KLINK DT, GLICK MC, SCANLIN TF: Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose. Glycocenj. J. (2001) 18(9):731-740.
70. KLINK DT, CHAO S, GLICK MC, SCANLIN TF: Nuclear translocation of lactosylated poly-L-lysine/cDNA complex in cystic fibrosis airway epithelial cells. Mol. Ther. (2001) 3(6):831-841.
71. WU GY, WU CH: Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. (1988) 263:14621-14624.
72. WILSON JM, GROSSMAN M, WU CH, CHOWDHURY NR, WU GY, CHOWDHURY JR: Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in lipoprotein receptor-deficient rabbits. J. Biol. Chem. (1992) 267:963-967.
73. CHOWDHURY NR, WU CH, WU GY, YERNENI PC, BOMMINENI VR, CHOWDHURY JR: Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. J. Biol. Chem. (1993) 268:11265-11271.
74. COTTEN M, WAGNER E, ZATLOUKAL K, BIRNSTIEL ML: Chicken adenovirus (CELO) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J. Virol. (1993) 67:3777-3785.
75. CHRISTIANO RJ, SMITH LC, WOO SL: Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. USA (1993) 90:2122-2126.
76. FERKOL T, PERALES JC, KAETZEL CS, ECKMAN E, HANSON RW, DAVIS PB: Gene transfer into always in animals by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. (1995) 95:493-502.
77. PERALES JC, FERKOL T, BEEGEN H, RATNOFF OD, HANSON RW: Gene transfer in vivo: sustained expression and regulation of genes introduced into the livers by receptor targeted uptake. Proc. Natl. Acad. Sci. USA (1994) 91:4086-4090.
78. RUDOLPH C, SCHILLINGER U, PLANK C et al.: Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim. Biophys. Acta. (2002) 1573(1):75-83.
79. ZIADY AG, FERKOL T, DAWSON DV, PERLMUTTER DH, DAVIS PB: Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J. Biol. Chem. (1999) 274(8):4908-4916.
80. KAETZEL CS, BLANCH VJ, HEMPEN PM, PHILLIPS KM, PISKURICH JF, YOUNGMAN KR: The polymeric immunoglobulin receptor: structure and synthesis. Biochem. Soc. Trans. (1997) 25(2):475-480.
81. KELLEY TJ, DRUMM ML: Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. (1998) 102:1200-1207.
82. HONG K, ZHENG W, BAKER A, PAPAHADJOPOULOS D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. (1997) 400:233-237.
83. OGRIS M, BRUNNER S, SCHULLER S, KIRCHEIS R. WAGNER E: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6:595-605.
84. PAPAHADJOPOULOS D, ALLEN TM, GABIZON A et al.: Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA (1991) 88:11460-11464.
85. GEDEON C, ZIADY AG, MILLER TJ et al.: High-level expression of compacted DNA complexes following intratracheal administration. Mol. Ther. (2000) 1(Suppl.):S78.
86. ZIADY AG, GEDEON C, PAYNE JM et al.: Stabilized PLASmin complexes deliver exogenous genes to the nasal epithelia of cystic fibrosis (CF) knockout mice and confer partial physiological correction of CFTR-mediated chloride transport. Mol. Ther. (2002) 5(Suppl.):S463.
87. PLANK C, MECHTLER K, SZOKA F, WAGNER E: Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. (1996) 7(12):1437-1446.
88. PLANK C, TANG MX, WOLFE AR, SZOKA FC JR: Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum. Gene Ther. (1999) 10(2):319-332.
89. ZIADY AG, GEDEON C, PAYNE JM et al.: Lack of typical inflammatory responses to CpG sequences following intrapulmonary administration of plasmid DNA compacted with PEG-substituted polylysine. Mol. Ther. (2002) 5(Suppl.):S463.
90. RUDOLPH C, LAUSIER J, NAUNDORF S, MULLER RH, ROSENECKER J: In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J. Gene Med. (2000) 2(4):269-278.
91. CHOLLET P, FAVROT MC, HURBIN A, COLL JL: Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. (2002) 4:84-91.
92. GAUTAM A, DENSMORE CL, GOLUNSKI E, XU B, WALDREP JC: Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol. Ther. (2001) 3(4):551-556.
93. GEBHART CL, KABANOV AV: Evaluation of polyplexes as gene transfer agents. J. Control Release (2001) 73:401-416.
94. GAUTAM A, DENSMORE CL, WALDREP JC: Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther. (2001) 8(3):254-257.
95. UDUEHI AN, STAMMBERGER U, KUBISA B, GUGGER M, BUEHLER TA, SCHMID RA: Effects of linear polyethylenimine and polyethylenimine/DNA on lung function after airway instillation to rat lungs. Mol. Ther. (2001) 4(1):52-57.
96. CUNNINGHAM S, MENG QH, KLEIN N, MCANULTY RJ, HART SL: Evaluation of a porcine model for pulmonary gene transfer using a novel synthenic vector. J. Gene Med. (2002) 4(4):438-446.
97. SANDERS NN, DE SMEDT SC, CHENG SH, DEMEESTER J: Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. Gene Ther. (2002) 9(6):363-371.
98. COLIN M, HARBOTTLE RP, KNIGHT A et al.: Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther. (1998) 5(11):1488-1498.
99. KOEHLER DR, HANNAM V, BELCASTRO R et al.: Targeting transgene expression for cystic fibrosis gene therapy. Mol. Ther. (2001) 4(1):58-65.
100. GILL DR, SMYTH SE, GODDARD CA et al.: Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1 alpha promoter. Gene Ther. (2001) 8(20):1539-1546.